Colorectal Clinical Trials
To inquire about participating in these studies, call 1-877-ASK-RPCI (1-877-275-7724).
N1048 PROSPECT**) A Phase II/III Trial of Neoadjuvant FOLFOX with Selective Use of Combined Modality Chemoradiaiton Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection...
Principal Investigator: Nurkin, Steven J
A Phase II Study of the Combination of Aflibercept (VEGF-Trap) plus Modified FOLFOX 6 in Patients with Previously Untreated Metastatic Colorectal Cancer
Principal Investigator: Ma, Wen Wee
(R1400-ST-1113) Phase I Study of REGN1400 in Combination with Erlotinib or Cetuximab Administered in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) or Head and Neck Cancer (SCCHN)
Principal Investigator: Adjei, Alex
Intensity Modulated Radiation Therapy for Anal Cancer: Dosimetric Comparison, Acute Toxicity Profile, and Quality of Life Assessment
Principal Investigator: Mattson, David